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Flavonoids (or bioflavonoids) are a group of about 4000
naturally occurring compounds that are ubiquitous in vascu-
lar plants. These compounds are responsible for the autumnal
burst of hues and the many shades of yellow, orange, and red
in flowers. They are also important for the normal growth,
development, and defense of plants.1) Flavonoids occur in
several medicinal plants, and herbal remedies containing
flavonoids have been indicated in folk medicine around the
world.2) Thus these compounds are important for plants, ani-
mals, and humans.
The relationship between flavonoids and humans has stim-
ulated the study of the biochemical, physiologic, and phar-
macologic activities of these compounds. Flavonoids have
antiinflammatory activity3) and protect the gastric mucosa
against a variety of ulcerogenic agents in different mam-
malian species. As a result, many studies have examined the
antiulcerogenic activities of plants containing flavonoids
using either naturally derived or synthetic compounds.2) De-
spite some promising results obtained with this class of mol-
ecules, there are currently few flavonoid related to antiul-
cerogenic properties.
Turnera ulmifolia L., a plant popularly known in Brazil
and South America as chanana, belongs to the family Turner-
aceae. This species is a small herb with a wide geographic
distribution, ranging from Guyana to southeastern Brazil, 
including São Paulo state, where it is considered a weed.4)
Some species of Turnera are used in folk medicine for the
treatment of several diseases. Recently, Antonio and Souza
Brito5) demonstrated in rats that organic extracts from T. ul-
mifolia inhibited gastric lesions induced by ligature of the
pylorus, and by indomethacin and ethanol. Those authors
also detected flavonoids in these preparations.
Since the tea of this species is used in folk medicine to
treat gastric ulcers in Brazil and other South American coun-
tries, we investigated the antiulcerogenic properties of a
lyophilized infusion obtained from the aerial parts of T. ulmi-
folia, in different models of gastric ulcer in mice. We also
screened the extract for the presence of different classes of
natural products to determine whether there was a correlation
between the chemical composition of the infusion and the bi-
ological activity of the tea.
MATERIAL AND METHODS
Animals Fasted male Swiss albino mice (30—40 g) or
male Wistar rats (200—220 g) from the Central Animal
House of the State University of Campinas (CEMIB/UNI-
CAMP) were used. The animals were fed a certified Nuvilab
CR-a diet with free access to tap water, and were housed
under standard conditions of illumination (12 h light/dark),
humidity (6061%), and temperature (21.562 °C). All of the
experimental protocols were approved by the local Commit-
tee for Ethics in Animal Experimentation at UNICAMP.
Drugs All reagents were of the highest purity. The fol-
lowing drugs were used: absolute ethanol, acetic acid,
bethanechol chloride, cimetidine, cysteamine, indomethacin,
lansoprazole, sodium bicarbonate, (Sigma Chemical, St.
Louis, MO, U.S.A.). The AqF was always dissolved in 0.9%
NaCl and administered at doses of 100, 250, 500, and
1000 mg/kg p.o. or intraduodenally, depending on the experi-
ment. All solutions, reagents, and aqueous fraction (AqF)
were prepared immediately before use.
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Turnera ulmifolia is a plant belonging to the family Turneraceae, popularly known in Brazil as chanana.
This species is distributed from Guyana to southern Brazil where it is considered a weed. The plant occurs in
tropical rain forest, fields, and gardens. Chanana tea is used in Brazilian folk medicine for the treatment of dis-
eases related mainly to gastric dysfunction including gastric and duodenal ulcers. In this study, the ability of a
lyophilized infusion, as an aqueous fraction (AqF) of the aerial parts of T. ulmifolia, was investigated for its abil-
ity to prevent ulceration of the gastric and duodenal mucosa was examined in mice and rats, respectively. The
AqF significantly reduced the formation of lesions associated with HCl/ethanol administration by 39% and 46%,
respectively, at doses of 500 mg/kg and 1000 mg/kg, p.o. The AqF also significantly reduced the incidence of gas-
tric lesions induced by a combination of indomethacin and bethanechol by 58% and 72% at doses of 500 mg/kg
and 1000 mg/kg, respectively. In stress-induced gastric ulcer, the inhibition by the AqF was 48%, 57%, and 58%
at doses of 250 mg/kg, 500 mg/kg, and 1000 mg/kg, respectively (p,0.05). A pyloric ligature experiment showed
that the highest dose of the AqF significantly affected the gastric juice parameters by increasing the pH from 2.5
(control) to 5.3 and decreasing the acid output from 11.3 (control) to 3.7 mEq/ml/4 h. The AqF had no significant
effect on duodenal ulcers induced by cysteamine. Preliminary phytochemical screening confirmed that flavonoids
were the major constituents of the AqF of T. ulmifolia. These results indicate that this extract has a significant
antiulcerogenic effect, as popularly believed.
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Plant Material Specimens of T. ulmifolia were collected
in 1999 in the city of Porto Nacional, Tocantins, and were
identified and authenticated by Dr. Solange de Fátima Lolis
at the Biology and Public Health Institute of the University
of Tocantins, Brazil. A voucher specimen (number 0071) was
deposited in the HTINS herbarium located in the same uni-
versity.
Infusion Preparation Dried, powdered aerial parts of T.
ulmifolia (50 g) were infused with 500 ml of boiling water to
give a 10% solution. The infusion was allowed to cool to
room temperature before being filtered and lyophilized. This
procedure yielded 2 g of lyophilized aqueous extract and was
repeated several times to obtain sufficient material for the 
biological assays. Lyophilized samples were homogenized to
produce a final AqF and the resulting sample was stored
under refrigeration until the experiment.
Hippocratic Screening and Acute Toxicity The signs
and symptoms associated with the oral administration of the
AqF (500, 1000, 2500, and 5000 mg/kg) were monitored in 8
mice per dose. The mice were examined 0, 5, 1, 2, 4, 8, 24,
and 48 h after administration of the infusion to assess possi-
ble clinical or toxicological symptoms. The mortality rate
was monitored for a period of 2 weeks, as described by
Souza Brito.6)
Antiulcerogenic Activity. Ethanol/HCl-Induced Gastric
Mucosal Lesions These experiments were performed using
the method of Mizui and Doteuchi,7) with some modifica-
tions. Mice were fasted for 24 h and then given the AqF at
doses of 100, 250, 500, and 1000 mg/kg. Lansoprazole
(30 mg/kg) or vehicle (NaCl 0.9%) was administered orally
to the control mice. Fifty minutes after the administrations,
all mice received an oral dose of 0.2 ml of 0.3 M HCl/60%
ethanol solution and were killed by cervical dislocation 1 h
later. The stomach was inflated by injecting 2 ml of normal
saline and then opened along the greater curvature before fix
in 5% formalin for 30 min. The ulcerative lesion index (ULI)
was calculated as described by Szelenyi and Thiemer.8)
Hypothermic Restraint Stress-Induced Lesions The
method of Levine9) was used, with some modifications. Mice
were fasted for 36 h and then immobilized in a restraint cage
at 4 °C for 4 h. The AqF from T. ulmifolia (100, 250, 500,
1000 mg/kg), cimetidine (100 mg/kg), or saline was adminis-
tered 1 h before the stress procedure. The mice were killed
and the stomach was removed and opened along the greater
curvature to determine the ULI as described above.
Indomethacin-Induced Gastric Lesions in Choli-
nomimetic-Treated Mice These experiments were carried
out as described by Rainsford.10) In this model, gastric 
lesions were induced by administering indomethacin
(30 mg/kg, s.c.) and bethanechol (5 mg/kg, i.p.); the drugs
were administered to mice after a 36 h fast. The AqF (100,
250, 500, 1000 mg/kg), cimetidine (100 mg/kg, p.o.), or
saline was administered 30 min before the induction of gas-
tric lesions. The mice were killed 4 h after treatment with the
ulcerogenic agents, and the stomachs were removed and in-
flated with 4% formalin in buffered saline to determine the
ULI as described above.
Determination of Gastric Secretion This assay was
performed using the method of Shay et al.,11) with minor
modifications. All groups of mice were fasted for 36 h, with
free access to water. Immediately after pyloric ligation, the
AqF (100, 250, 500, 1000 mg/kg), cimetidine (100 mg/kg),
or saline was administered intraduodenally. The mice were
killed 4 h later, and the abdomen was opened and the stom-
achs removed. The amount of gastric juice (mg) and the pH
were determined. The total acidity of the gastric secretions
was determined by titration with 0.01 N NaOH to pH 7.0.
Cysteamine-Induced Duodenal Ulcers Acute duodenal
lesions were induced in four groups of rats according to the
method of Szabo.12) The rats received two oral administra-
tions of cysteamine HCl (400 mg/kg) in 1 ml of distilled
water at a 4 h interval to produce the duodenal lesions. The
AqF (500, 1000 mg/kg), cimetidine (100 mg/kg), or saline
was given orally 1 h prior to cysteamine challenge. All rats
were killed 48 h after the first administration of cysteamine
and the duodenum was removed and scored for the presence
of lesions.
Chromatographic Analysis of the AqF from T. ulmifo-
lia The chemical constituents present in the lyophilized in-
fusion of T. ulmifolia were identified according to the method
of Wagner et al.13) The chromatographic analyses were done
on glass plates (5—30 cm) coated with Fluka F254 silica gel
0.25 mm thick and eluted in three different solvent systems:
n-butanol/acetic acid/water (BAW) 65 : 15 : 35 v/v; chloro-
form/methanol/ammonia 8 : 2 : 0.5 v/v; and chloroform/
methanol/n-propanol/water 5 : 6 : 1 : 4 v/v (lower layer). The
AqF (10 mg) was dissolved in 1 ml of a 1 : 1 v/v mixture of
methanol–water, submitted to an ultrasonic bath for 5 min,
and centrifuged. Approximately 10 m l of the solution was
spotted onto the TLC plate. Alkaloids were detected by
spraying the plates with Dragendorff’s reagent or iodoplati-
nate. Anthraquinones were detected using 10% potassium
hydroxide solution in methanol. Flavonoids were detected by
their intense fluorescence in visible or UV light when devel-
oped with a natural product/polyethylene glycol (NP/PEG)
reagent. General phenolic compounds were detected after ex-
posing the plates to ammonia vapors and immediately ob-
serving the fluorescent spots under UV light. Saponins,
triterpenes, and steroids were detected either with anisalde-
hyde–sulphuric acid reagent or sulphate–sulphuric acid solu-
tion, which produced a range of colors after heating for 5 min
at 100 °C. Tannins were detected with 5% ferric chloride so-
lution in methanol and with 1% gelatin solution. Standard
solutions of rutin, isoquercetrin, chlorogenic acid, and cate-
chin were prepared in methanol.
Statistical Analysis The results are expressed as the
mean6S.D. and significant differences in the ULI were de-
termined by one-way analysis of variance (ANOVA) fol-
lowed by Tukey’s (among groups) or Dunnett’s (relative to
the negative control group) pairwise tests. ANOVA was used
to analyze the linear fit of the dose-response curves, and 
the ED50 values were determined to confirm the dose depen-
dence of the AqF effects. p values of less than 0.05 were con-
sidered significant in all analyses.
RESULTS AND DISCUSSION
Based on the phytochemical screening shown in Table 1,
flavonoids were apparently present as secondary metabolites
in the infusion of T. ulmifolia aerial parts. Other classes of
products with no known antiulcer activity were also present
as minor compounds.
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Numerous investigations have concluded that flavonoids
play a central role in the antiulcer and antiinflammatory 
activities of plants.2,3,14) Recently, the antioxidant activity of
flavonoids has attracted interest because of strong evidence
that oxidation processes are involved in the mechanisms of
several gastric disorders, including ulcerogenesis.14,17)
Preparations such as infusions, extracts, or fractions con-
taining flavonoids as the major compounds generally produce
no significant acute toxicity in vivo. In agreement with this,
no signs or symptoms of acute toxicity were observed with
any of the doses of the AqF. There were no significant differ-
ences in organ weight, in water or food intake or in the
amount of feces produced by AqF-treated and control mice.
None of the treated mice died during the 14 d of observation
after the administration of the AqF. These findings indicate
that the AqF from T. ulmifolia is safe in mice at doses of up
to 5000 mg/kg p.o. However, the possible effects in other
species have yet to be studied.
The antiulcerogenic activity of the AqF was assayed in
distinct models of ulcerative gastric and duodenal lesions in
mice and rats, respectively. Gastric acid is secreted from the
parietal cells by a proton pump and is stimulated by acetyl-
choline, histamine, and gastrin.18) Anticholinergic and anti-
histaminergic drugs block the action of acetylcholine and
histamine at muscarinic M3 receptors and histaminergic H2
receptors located in the basolateral membrane of parietal
cells. In contrast, proton pump inhibitors such as lansopra-
zole act directly on H1/K1-ATPase, the final step in acid se-
cretion, and therefore control acid secretion independently of
the stimuli acting the parietal cells.19,20)
Prostaglandins are involved in the regulation of a variety
of gastrointestinal functions, including blood flow and acid,
mucus, and HCO3 secretion. Mucus and HCO3 released from
the surface of epithelial cells are part of the mucosal defen-
sive mechanisms and play an important role in protecting the
gastroduodenal mucosa. Although the physiological regula-
tion of mucus and HCO3 release involves neuronal factors,
prostaglandin E2 is also important in the local control of this
secretion.18,20,22) Some plant extracts containing flavonoids
can inhibit H1/K1-ATPase proton pump activity or increase
PGE2 and mucus release, which could explain their antiul-
cerogenic action.2)
Mice pretreated with the AqF showed a significant reduc-
tion in ethanol induced gastric ulcers at doses of 500 and
1000 mg/kg (Table 2), although the effect was not dose de-
pendent. These results indicate that compounds present in the
AqF interfered with the ulcerogenic activity of ethanol.23)
Cytoprotective drugs alone or in combination with antisecre-
tory drugs have commonly been used to treat alcohol induced
gastric ulcer in humans. Plants containing flavonoids are also
effective in preventing this kind of lesion, mainly because of
their antioxidant properties.1,3)
The AqF also significantly prevented the formation of
stress-induced lesions at doses of 250, 500, and 1000 mg/kg
(Table 3). Again, no dose dependence effect was observed,
and there was no difference between the doses of 500 and
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Table 2. Effects of T. ulmifolia AqF and Lansoprazole on HCl/Ethanol-Induced Gastric Ulcer in Mice
Treatment Dose (mg/kg) ULI Inhibition (%) r value p value ED50 (mg/kg)
Control — 34.769.5 — — — —
Lansoprazole 100 9.065.1a) 76 — — —
AqF 100 32.768.8b) 5
250 25.464.9b) 18 0.6 8.2 196.2
500 20.865.0a) 39
1000 18.466.4a) 46
ULI analysis: ANOVA2F(5,36)56.41; Tukey test. p,0.05 for a) lansoprazole and AqF (500, 1000 mg/kg) vs. negative control, and b) AqF (100, 250 mg/kg) vs. lansoprazole
(n57).
Table 3. Effects of T. ulmifolia AqF and Cimetidine on Stress-Induced Gastric Ulcer in Mice
Treatment Dose (mg/kg) ULI Inhibition (%) r value p value ED50 (mg/kg)
Control — 12.162.6 — — — —
Cimetidine 100 3.961.6a) 68 — — —
AqF 100 13.462.7b) 10
250 6.362.1a,c) 48 0.6 4.9 759.8
500 5.162.9a,c) 57
1000 5.062.0a,c) 58
ULI analysis: ANOVA2F(5,42)523.66; Tukey test. p,0.05 for a) cimetidine and AqF (250, 500, 1000 mg/kg) vs. negative control; b) AqF (100 mg/kg) vs. cimetidine, and c)
AqF (250, 500, 1000 mg/kg) vs. AqF (100 mg/kg), (n58).
1000 mg/kg, which produced 57 and 58% inhibition, respec-
tively. The prevention of stress-induced lesions by the AqF
most likely involved an action on gastric secretion.20) Antise-
cretory drugs such as cimetidine, lansoprazole, and other 
potent antisecretory drugs are used to treat this type of lesion
in humans. However, various agents of vegetable origin with
antioxidant properties or containing free radical scavengers
have also demonstrated good activity when used to treat
stress and ulcers induced by stress in rodents.2,24)
The gastric ulcers produced by the cyclooxygenase 1 and 
2 inhibitor indomethacin25) given in combination with a
parasympatomimetic drug were prevented by the AqF (Table
4) at doses of 500 and 1000 mg/kg. This time, the effect was
dose dependent. Antisecretory drugs and cytoprotective
drugs such as prostaglandin analogues or other agents that
protect the gastric mucosa, alone or in combination, are gen-
erally used to treat this type of lesion in clinical practice.
Various plants containing flavonoids are also able to increase
gastric mucus and bicarbonate secretion as well as PGE2 re-
lease from the gastric mucosa, thereby preventing the ulcera-
tion induced by NSAIDs in rats.2,3,14)
When the normal stomach motility was altered by ligation
of the pylorus26) and cimetidine or the AqF was given in-
traduodenally, there was a significant increase in the gastric
juice pH and decreased of acid output (1000 mg/kg) but no
change in the amount of gastric juice was produced (Table
5). These data show again that a possible antisecretory effect
is involved in the antiulcerogenic activity of the substances
present in the AqF. The action of the AqF when administered
intraduodenally agrees with the observation that flavonoids
can be fully or partially absorbed from the gastrointestinal
tract.24)
The AqF had no significant effect against duodenal ulcers,
with only 17 and 25% inhibition of their formation occurring
at doses of 500 and 1000 mg/kg, respectively (data not
shown). However, a higher dose of purified flavonoids could
have a significant effect in preventing such lesions in rats.
The antiulcerogenic activity of many plant species is re-
lated to their content of flavonoids. Spartium junceum L., a
species used in Turkish folk medicine to treat gastric ulcer,
contains glycosylated flavonoids with antioxidant activity.27)
A flavonoid present in unripe plantain banana pulp (Musa
sapirntum L.) protects the gastric mucosa from aspirin-in-
duced lesions.28) Similarly, the flavonoid hypolaetin-8-gluco-
side present in several species of the genus Sideritis also has
significant antiulcerogenic activity.29) The synthetic isoprenyl
flavonoid Solon shows good antiulcerogenic and gastropro-
tective effects. This compound is derived from sophoradin, a
flavonoid isolated from the traditional Chinese medicinal
plant Sophora subprostata. The exact mechanism of its ac-
tion remains unclear, but may involve an action on the pro-
duction and metabolism of prostaglandins and mucus in the
gastric mucosa.30)
Our data suggest that the effects of the T. ulmifolia infu-
sion are probably related to an increase in prostaglandin or
mucus formation, inhibition of H1/K1-ATPase of the gastric
mucosa, or possibly to antioxidant and free radical-scaveng-
ing activity, since all of these mechanisms are related to
flavonoid content in other species.2,14,17,27) Various com-
pounds detected in minor concentrations in the AqF showed
no antiulcer activity and did not belong to the classes of
chemical substances described by Lewis31) as having antiul-
cerogenic properties.
Although the precise nature of the active components of
the AqF is still not known, we have found that the flavonoids
present in the AqF are C-glycosylated flavones derivated
from luteonin and apigenin (Vilegas et al., unpublished data).
The results of this study support the use of infusions of T. ul-
mifolia to treat general ulcers, and suggest that this species
could provide useful phytotherapeutic agents for the treat-
ment of gastric ulcers in humans.
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Table 4. Effects of T. ulmifolia AqF and Cimetidine on Indomethacin- and Bethanechol-Induced Gastric Ulcer in Mice
Treatment Dose (mg/kg) ULI Inhibition (%) r value p value ED50 (mg/kg)
Control — 15.963.9 — — — —
Cimetidine 100 8.464.0a) 76 — — —
AqF 100 14.363.2b) 10
250 11.163.2b) 29 0.790* 0.001 664.1
500 6.661.7a,c,d) 58
1000 4.462.2a,c,d,e) 72
ANOVA–Linerar fit ∗ p,0.05; ULI analysis: F(5,36)514.18; Tukey test. p,0.05 for a) cimetidine and AqF (500, 1000 mg/kg) vs. negative control; b) AqF (100, 250 mg/kg) vs.
cimetidine; c) AqF (500, 1000 mg/kg) vs. 100 mg/kg; d) AqF (500, 1000 mg/kg) vs. AqF (250 mg/kg), and e) AqF (1000 mg/kg) vs. AqF (500 mg/kg), (n57).
Table 5. Effects of T. ulmifolia AqF Intraduodenally and of Cimetidine on the Biochemical Parameters of Gastric Juice in Pylorus-Ligated Mice
Treatment Dose (mg/kg) n pH (units) Gastric juice (mg) Acid output 4 h (mEq/ml)
NaCl 0.9% 10 ml/kg 8 2.5660.48 336687 11.3462.35
Cimetidine 100 8 5.5661.03* 213697 5.1661.23*
AqF 250 8 3.3760.78 295676 8.9261.61
500 8 3.7560.96 327689 6.2361.03*
1000 8 5.3761.81* 292677 3.7160.67*
Analysis of biochemical parameters: ANOVA F(4,35) pH58.59; gastric juice51.95; [H
1]514.89, p,0.05. Dunnett test, ∗ p,0.001 relative to the NaCl group.
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